ABPI Screening Before VLU Compression Therapy: A Decision Record for Long-Term Care Nurses

What Must Be Documented Before Compression Begins?

Quick Answer

Compression is central to venous leg ulcer care, but the decision must follow documented vascular assessment rather than wound appearance alone.[1][2] A usable record connects vascular-risk flags, the approved ABPI/Doppler finding, the compression decision, review timing and referral triggers. The downloadable record below is a direct DOCX file; access is handled through the resource request path.

1. Why This Decision Fails in Real Facilities

The problem is rarely that staff have never heard of ABPI. The problem is that the result, the professional interpretation and the compression plan do not remain connected through handover.

Common failures include:

– compression is started from wound appearance or habit;
– the ABPI/Doppler result is stored separately from the care plan;
– a change in compression is recorded without its professional basis;
– pain, discomfort or skin change is documented without a review action;
– the next shift sees the plan but not the referral or reassessment trigger.

This creates inconsistent decisions and makes later review difficult.

2. What ABPI Contributes to VLU Care

ABPI compares ankle and arm systolic pressures and contributes to lower-limb arterial assessment. In VLU care, it helps the professional team judge whether compression is appropriate, whether the plan requires modification, or whether vascular review is needed.[1][2]

ABPI does not diagnose every cause of a leg ulcer, and one number should not be interpreted outside the clinical context. Diabetes, calcification, symptoms, Doppler findings and local pathways can affect interpretation. This article therefore does not publish a universal compression threshold.

The institutional rule is simpler: record the vascular assessment and the approved decision before compression is executed.

3. The Five Fields That Make the Decision Reviewable

Record field	What to capture	Why it matters
Vascular-risk flags	Relevant history, symptoms, pulses and concerns identified by the professional team	Prevents a surface-only decision
ABPI/Doppler result	Date, side, method, result and source of professional interpretation	Keeps the evidence with the plan
Approved compression decision	Approved type/intensity, modified plan, deferral or referral	Prevents verbal-only instructions
Review and stop conditions	Review date, changes requiring pause, and escalation contact	Connects observation to action
Handover ownership	Responsible person, next action and receiving staff member	Stops the decision from disappearing between shifts

The form should record the approved decision; it should not ask staff to independently invent a compression prescription.

4. A Simple Proceed, Pause or Escalate Route

Evidence boundary: Published wIRA study observations are provided as technology-background context. They are not CYP8 brand-specific clinical evidence, treatment instructions, or a guarantee of wound healing, pain reduction, functional recovery, or any individual clinical outcome.

Proceed

The vascular assessment, professional interpretation, compression plan and review route are documented and executable.

Pause

The result is missing, unclear, internally inconsistent or no longer matches the current presentation. Return the case to the responsible professional pathway before continuing.

Escalate

New warning signs, significant pain change, skin deterioration, circulation concerns or a predefined stop condition appear. Stop the current action and use the institution’s established escalation route.

These labels organize responsibility; they do not replace professional assessment.

5. Compression Remains the Standard-Care Foundation

NICE, EWMA and international consensus documents place compression at the centre of VLU management after appropriate vascular assessment.[1][2][3]

The ABPI record does not compete with compression. It protects the decision chain around compression by showing:

1. why the selected route was approved;
2. who authorised it;
3. what staff should observe;
4. when the plan should be reviewed;
5. when the case must return to the professional pathway.

6. What Can wIRA Evidence Add After Vascular Assessment and Compression Planning?

ABPI/Doppler assessment and compression planning remain the decision foundation. wIRA evidence becomes relevant only after the vascular boundary and standard-care plan are clear.

Study	What was observed	What it does not prove
Schumann et al., 2011: 51-person randomized, controlled and blinded study	The primary ulcer-area-over-time measure was not statistically significant. Secondary findings favoured wIRA for clinician-rated wound-status observation, the proportion showing a secondary wound-status trend and granulation.[4]	It does not show that wIRA replaces compression or that every ulcer will respond.
Mercer et al., 2008: 10 people with 11 recalcitrant ulcers	Seven participants reached complete or near-complete closure and two others had marked ulcer-size reduction; pain-score, analgesic-use, and thermographic observations were also reported.[5]	It was a small, mainly single-cohort study and is not CYP8 brand evidence.

No Basel closure-time figures are used here. Later reviews report conflicting values, and the complete original report has not been independently verified.

These studies support professional review of wIRA as an adjunctive tissue-environment support pathway. Suitability still depends on vascular assessment, compression planning, professional confirmation, product instructions and institutional rules.

7. Where CYP8 Fits

CYP8 may be evaluated as an equipment-delivery layer after the vascular and compression pathway is established. It does not measure ABPI, determine compression intensity, assess perfusion or replace professional review.

If introduced, the institution should record operator, setting, time, position/distance, tolerance, visible or subjective feedback, stop/escalation events and handover. Any operating decision remains subject to the product instructions and the institution’s professional responsibility chain.

8. Download the ABPI and Compression Decision Record

Request access to the VLU Workflow Resource Pack

Use it to record vascular-risk flags, the documented ABPI/Doppler result, the approved compression decision, review timing and referral triggers.

The link is a resource access. No email entry is required.

9. Continue With the Full VLU Pathway

ABPI is one decision gate inside a wider VLU pathway. Compression execution, wound-bed care, mobility, skin protection and recurrence prevention still require coordinated review.

Common Questions About ABPI and VLU Compression

Why is ABPI reviewed before compression therapy?
ABPI is commonly reviewed as part of vascular assessment before compression decisions. It helps teams document whether escalation or further vascular review is needed before compression is applied.

What should be documented before a compression decision?
Teams usually document ABPI / vascular assessment status, wound context, contraindication concerns, compression tolerance, handover notes, and escalation decisions.

When should VLU compression be escalated for vascular review?
Escalation should be considered when vascular assessment is incomplete, ABPI results are outside local protocol boundaries, symptoms raise concern, or the care team needs specialist confirmation.

Related VLU Guides

Resources

VLU Workflow Resource Pack

Institutional overview for VLU workflow review, handover preparation, and resource planning.

View resource

Download Center

Browse CYP8 resources by indication, workflow use, and institutional review need.

Open Download Center

Resources are intended for institutional review, workflow discussion, and professional education. They are not diagnostic tools, treatment instructions, or guarantees of clinical outcomes.

References

1. National Institute for Health and Care Excellence. Clinical Knowledge Summary: Leg ulcer – venous. Official source.
2. European Wound Management Association and Wounds Australia. Management of Patients with Venous Leg Ulcers: Challenges and Current Best Practice. 2016. Official PDF.
3. Harding K, et al. Simplifying venous leg ulcer management: consensus recommendations. Wounds International. 2015. Official source.
4. Schumann H, Calow T, Weckesser S, Müller ML, Hoffmann G. Water-filtered infrared A for the treatment of chronic venous stasis ulcers of the lower legs at home: a randomized controlled blinded study. British Journal of Dermatology. 2011;165(3):541-551. PMID: 21574975. DOI: 10.1111/j.1365-2133.2011.10410.x. PubMed.
5. Mercer JB, Nielsen SP, Hoffmann G. Improvement of wound healing by water-filtered infrared-A in patients with chronic venous stasis ulcers of the lower legs including evaluation using infrared thermography. GMS German Medical Science. 2008;6:Doc11. PMID: 19675738. PMCID: PMC2703263. PubMed.